TCT 2019 | STS/ACC TVT Registry: Relationship Between MitraClip Operator Experience and Events

Courtesy of SBHCI.

Mitral valve repair with a MitraClip device is a complex procedure that requires that operators develop a series of skills that may be unusual for them, such as analyzing an echocardiography.

Highlights TCT 2019

In this registry, researchers assessed the relationship between operator experience and procedural outcome.

Operators were classified into 3 groups: 1 to 25 procedures conducted, 26 to 50 procedures conducted, and 50+ procedures conducted. Researchers assessed the rates of procedural success, procedural time, and in-hospital complications.

The study analyzed 14,923 MitraClip procedures conducted by 562 operators in 290 sites. Optimal success rates (regarded as mitral regurgitation grade 1 or less) increased alongside operator experience (63.9%, 68.4%, and 75.1%, respectively; p < 0.0001). Acceptable success rates (regarded as regurgitation grade 2 or less) also increased alongside the number of procedures conducted (91.4%, 92.4%, and 93.8%; p < 0.001).

The cutoff point as regards the success rate and the rate of complications was clear at 50 procedures, but outcomes continued improving up to 200 procedures.

Courtesy of SBHCI.

Link to the SBHCI publication HERE

Original Title: STS/ACC TVT Registry: MitraClip Operator Volume-Outcome Relationship in the United States.

Author of the original title: Adnan K. Chhatriwalla.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

T-TEER: Beyond Traditional Pulmonary Hypertension Thresholds

Significant tricuspid regurgitation (TR) is associated with progressive functional deterioration, heart failure (HF) hospitalizations, and increased mortality. In recent years, transcatheter tricuspid edge-to-edge repair...

Is left atrial appendage closure safe in patients with reduced ejection fraction?

Patients with heart failure with reduced ejection fraction (HFrEF) were excluded from the major randomized trials evaluating percutaneous left atrial appendage closure (LAAC), and...

Left Atrial Appendage Closure in Spain: Sustained Growth and Favorable Real-World Outcomes

Oral anticoagulation remains the standard treatment for stroke prevention in patients with atrial fibrillation. However, many patients have a high bleeding risk or contraindications...

HERA-TAVI: Intra-Annular vs Supra-Annular Valves in TAVI

The HERA-TAVI study is an international multicenter registry that compared the clinical and hemodynamic outcomes of contemporary self-expanding transcatheter heart valves with intra-annular (IA)...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

T-TEER: Beyond Traditional Pulmonary Hypertension Thresholds

Significant tricuspid regurgitation (TR) is associated with progressive functional deterioration, heart failure (HF) hospitalizations, and increased mortality. In recent years, transcatheter tricuspid edge-to-edge repair...

Is left atrial appendage closure safe in patients with reduced ejection fraction?

Patients with heart failure with reduced ejection fraction (HFrEF) were excluded from the major randomized trials evaluating percutaneous left atrial appendage closure (LAAC), and...

Left Atrial Appendage Closure in Spain: Sustained Growth and Favorable Real-World Outcomes

Oral anticoagulation remains the standard treatment for stroke prevention in patients with atrial fibrillation. However, many patients have a high bleeding risk or contraindications...